FindTrial
Sign In

Use of statins and patient compliance with statin therapy among Type-2 diabetics patients with dyslipidemia

Evaluation of Drug Utilization and Patient Compliance with Statin Therapy Among Type-2 Diabetes Mellitus Patients with Dyslipidemia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070298
Enrollment
143
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years and above diagnosed,Type 2 diabetes mellitus with dyslipidemia and are on statin therapy for a minimum of one month or more, in the Inpatient Department of General Medicine will be included in the study.

Exclusion criteria

Exclusion criteria: Pregnant women, psychiatric illness patients, and cancer patients will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
-Identifying the drug utilization and patient compliance with statin therapy. Timepoint: 8 months—

Secondary

MeasureTime frame
-The drug-related problems among type 2 diabetes mellitus patients with dyslipidemia.Timepoint: 8 months;-The glycemic control and diabetic complications among the study population.Timepoint: 8 Months—

Countries

India

Contacts

Public ContactDr Adithi Kellarai

NGSM Institute of Pharmaceutical Sciences

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026